Baxter Gross Margin 2010-2025 | BAX
Current and historical gross margin for Baxter (BAX) over the last 10 years. The current gross profit margin for Baxter as of June 30, 2025 is %.
| Baxter Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $10.89B | $3.84B | 35.31% |
| 2025-03-31 | $10.77B | $3.88B | 36.06% |
| 2024-12-31 | $10.64B | $3.98B | 37.46% |
| 2024-09-30 | $8.42B | $3.73B | 44.31% |
| 2024-06-30 | $8.32B | $3.76B | 45.12% |
| 2024-03-31 | $9.34B | $3.84B | 41.08% |
| 2023-12-31 | $10.36B | $4.15B | 40.06% |
| 2023-09-30 | $8.97B | $3.23B | 35.99% |
| 2023-06-30 | $9.98B | $3.22B | 32.24% |
| 2023-03-31 | $9.86B | $3.48B | 35.24% |
| 2022-12-31 | $10.06B | $3.55B | 35.29% |
| 2022-09-30 | $13.79B | $4.79B | 34.71% |
| 2022-06-30 | $13.40B | $5.06B | 37.76% |
| 2022-03-31 | $12.91B | $4.92B | 38.14% |
| 2021-12-31 | $12.15B | $4.72B | 38.86% |
| 2021-09-30 | $12.45B | $4.89B | 39.27% |
| 2021-06-30 | $12.20B | $4.76B | 39.06% |
| 2021-03-31 | $11.82B | $4.57B | 38.66% |
| 2020-12-31 | $11.67B | $4.59B | 39.30% |
| 2020-09-30 | $11.53B | $4.69B | 40.71% |
| 2020-06-30 | $11.41B | $4.73B | 41.45% |
| 2020-03-31 | $11.53B | $4.84B | 42.03% |
| 2019-12-31 | $11.36B | $4.76B | 41.90% |
| 2019-09-30 | $11.14B | $4.64B | 41.62% |
| 2019-06-30 | $11.05B | $4.64B | 41.97% |
| 2019-03-31 | $11.06B | $4.73B | 42.72% |
| 2018-12-31 | $11.10B | $4.76B | 42.88% |
| 2018-09-30 | $11.08B | $4.75B | 42.91% |
| 2018-06-30 | $11.02B | $4.65B | 42.19% |
| 2018-03-31 | $10.79B | $4.54B | 42.13% |
| 2017-12-31 | $10.58B | $4.47B | 42.27% |
| 2017-09-30 | $10.43B | $4.41B | 42.31% |
| 2017-06-30 | $10.28B | $4.36B | 42.35% |
| 2017-03-31 | $10.26B | $4.20B | 40.87% |
| 2016-12-31 | $10.16B | $4.12B | 40.50% |
| 2016-09-30 | $10.12B | $4.08B | 40.31% |
| 2016-06-30 | $10.05B | $4.04B | 40.23% |
| 2016-03-31 | $9.94B | $4.09B | 41.17% |
| 2015-12-31 | $9.97B | $4.15B | 41.59% |
| 2015-09-30 | $10.15B | $4.28B | 42.16% |
| 2015-06-30 | $10.38B | $4.44B | 42.79% |
| 2015-03-31 | $12.06B | $5.39B | 44.70% |
| 2014-12-31 | $13.50B | $6.26B | 46.37% |
| 2014-09-30 | $15.03B | $7.05B | 46.89% |
| 2014-06-30 | $16.03B | $7.76B | 48.41% |
| 2014-03-31 | $15.55B | $7.73B | 49.73% |
| 2013-12-31 | $15.15B | $7.60B | 50.15% |
| 2013-09-30 | $14.33B | $7.34B | 51.23% |
| 2013-06-30 | $14.09B | $7.24B | 51.39% |
| 2013-03-31 | $14.00B | $7.18B | 51.27% |
| 2012-12-31 | $13.94B | $7.13B | 51.19% |
| 2012-09-30 | $14.03B | $7.16B | 51.04% |
| 2012-06-30 | $14.03B | $7.12B | 50.75% |
| 2012-03-31 | $14.00B | $7.09B | 50.62% |
| 2011-12-31 | $13.89B | $7.05B | 50.72% |
| 2011-09-30 | $13.80B | $6.90B | 50.00% |
| 2011-06-30 | $13.54B | $6.79B | 50.12% |
| 2011-03-31 | $13.20B | $6.59B | 49.92% |
| 2010-12-31 | $12.84B | $5.96B | 46.39% |
| 2010-09-30 | $12.82B | $6.11B | 47.66% |
| 2010-06-30 | $12.74B | $6.08B | 47.74% |
| 2010-03-31 | $12.67B | $6.08B | 48.01% |
| 2009-12-31 | $12.56B | $6.53B | 51.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $12.419B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.305B | 26.89 |
| Boston Scientific (BSX) | United States | $152.872B | 36.46 |
| Stryker (SYK) | United States | $146.007B | 29.72 |
| EssilorLuxottica (ESLOY) | France | $145.127B | 0.00 |
| Medtronic (MDT) | Ireland | $119.233B | 16.91 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.282B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.313B | 24.74 |
| ResMed (RMD) | United States | $41.712B | 29.83 |
| Agilent Technologies (A) | United States | $33.861B | 22.07 |
| GE HealthCare Technologies (GEHC) | United States | $33.512B | 15.75 |
| Terumo (TRUMY) | Japan | $27.642B | 32.75 |
| Koninklijke Philips (PHG) | Netherlands | $26.451B | 17.50 |
| Insulet (PODD) | United States | $22.615B | 75.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.354B | 12.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.855B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.731B | 28.40 |
| Lantheus Holdings (LNTH) | United States | $3.684B | 9.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.430B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.198B | 14.19 |
| Perrigo (PRGO) | Ireland | $3.123B | 7.80 |
| ICU Medical (ICUI) | United States | $2.986B | 20.33 |
| Haemonetics (HAE) | United States | $2.589B | 11.56 |
| LeMaitre Vascular (LMAT) | United States | $2.171B | 46.56 |
| Curaleaf Holdings (CURLF) | Canada | $1.782B | 0.00 |
| AtriCure (ATRC) | United States | $1.762B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.761B | 11.08 |
| Green Thumb Industries (GTBIF) | United States | $1.601B | 68.73 |
| AdaptHealth (AHCO) | United States | $1.283B | 18.24 |
| Phibro Animal Health (PAHC) | United States | $1.243B | 15.89 |
| Acuren (TIC) | United States | $1.190B | 0.00 |
| Neogen (NEOG) | United States | $1.179B | 18.72 |
| BioLife Solutions (BLFS) | United States | $1.166B | 2434.00 |
| Tilray Brands (TLRY) | Canada | $1.134B | 0.00 |
| Valneva SE (VALN) | France | $0.981B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 8.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.824B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.665B | 0.00 |
| Surmodics (SRDX) | United States | $0.536B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.482B | 0.00 |
| CeriBell (CBLL) | United States | $0.451B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.451B | 15.53 |
| Owens & Minor (OMI) | United States | $0.439B | 3.89 |
| Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
| Evolus (EOLS) | United States | $0.435B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.364B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.312B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.287B | 0.00 |
| Omeros (OMER) | United States | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.254B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 49.92 |
| Cerus (CERS) | United States | $0.238B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.212B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 0.00 |
| Biote (BTMD) | United States | $0.144B | 4.79 |
| Jushi Holdings (JUSHF) | United States | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.08 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.12 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.42 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.05 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.029B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |